235 related articles for article (PubMed ID: 12820463)
1. Tumor necrosis factor and isolated hepatic perfusion: from preclinical tumor models to clinical studies.
de Vries MR; ten Hagen TL; Marinelli AW; Eggermont AM
Anticancer Res; 2003; 23(2C):1811-23. PubMed ID: 12820463
[No Abstract] [Full Text] [Related]
2. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors.
Nakamoto T; Inagawa H; Takagi K; Soma G
Anticancer Res; 2000; 20(6A):4087-96. PubMed ID: 11131677
[TBL] [Abstract][Full Text] [Related]
3. Use of tumor necrosis factor in isolated hepatic perfusion.
Fraker DL; Alexander HR; Thom AK
Circ Shock; 1994 Sep; 44(1):45-50. PubMed ID: 7704938
[No Abstract] [Full Text] [Related]
4. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
[TBL] [Abstract][Full Text] [Related]
5. Isolated hepatic perfusion for the treatment of liver tumors: sunset or sunrise?
Verhoef C; de Wilt JH; ten Hagen TL; Eggermont AM
Surg Oncol Clin N Am; 2008 Oct; 17(4):877-94, xi. PubMed ID: 18722924
[TBL] [Abstract][Full Text] [Related]
6. Regional immunotherapy for liver metastases and the potential of TNF alpha in hepatic perfusion from laboratory to the clinic.
Eggermont AM
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1371-8. PubMed ID: 8854756
[No Abstract] [Full Text] [Related]
7. Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies.
Jones A; Alexander HR
Surg Oncol Clin N Am; 2008 Oct; 17(4):857-76, x. PubMed ID: 18722923
[TBL] [Abstract][Full Text] [Related]
8. Clinical and preclinical trials of isolated liver perfusion for advanced liver tumors: primary liver tumors.
Lowy AM; Curley SA
Surg Oncol Clin N Am; 1996 Apr; 5(2):429-41. PubMed ID: 9019362
[TBL] [Abstract][Full Text] [Related]
9. Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors.
Rothbarth J; Tollenaar RA; van de Velde CJ
Expert Rev Anticancer Ther; 2006 Apr; 6(4):553-65. PubMed ID: 16613543
[TBL] [Abstract][Full Text] [Related]
10. Regional chemotherapy: a focus on hepatic artery infusion for colorectal cancer liver metastases.
Dizon DS; Schwartz J; Kemeny N
Surg Oncol Clin N Am; 2008 Oct; 17(4):759-71, viii. PubMed ID: 18722916
[TBL] [Abstract][Full Text] [Related]
11. The past decade of experience with isolated hepatic perfusion.
Grover A; Alexander HR
Oncologist; 2004; 9(6):653-64. PubMed ID: 15561809
[TBL] [Abstract][Full Text] [Related]
12. Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver.
Alexander HR; Bartlett DL; Libutti SK
Cancer J Sci Am; 1998; 4(1):2-11. PubMed ID: 9467038
[No Abstract] [Full Text] [Related]
13. Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors.
Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Kuroda Y
Int J Clin Oncol; 2002 Apr; 7(2):82-90. PubMed ID: 12018114
[TBL] [Abstract][Full Text] [Related]
14. Where are we going with regional therapy for melanoma?
Tyler D
Ann Surg Oncol; 2004 May; 11(5):455-7. PubMed ID: 15078631
[No Abstract] [Full Text] [Related]
15. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
[TBL] [Abstract][Full Text] [Related]
16. TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.
Eggermont AM
Anticancer Res; 1998; 18(5D):3899-905. PubMed ID: 9854502
[TBL] [Abstract][Full Text] [Related]
17. Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability.
Lejeune FJ
J Clin Invest; 2002 Aug; 110(4):433-5. PubMed ID: 12189235
[No Abstract] [Full Text] [Related]
18. Isolated hepatic perfusion: experimental evidence and clinical utility.
de Wilt JH; van Etten B; Verhoef C; Eggermont AM
Surg Clin North Am; 2004 Apr; 84(2):627-41. PubMed ID: 15062665
[TBL] [Abstract][Full Text] [Related]
19. Current status of hyperthermic limb perfusion for in-transit melanoma.
Ross MI
Int J Hyperthermia; 2008 May; 24(3):205-17. PubMed ID: 18392999
[TBL] [Abstract][Full Text] [Related]
20. Theoretic and experimental aspects of regional liver infusion.
August DA
Surg Oncol Clin N Am; 1996 Apr; 5(2):399-409. PubMed ID: 9019360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
